Application Nr Approved Date Route Status External Links
NDA022201 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Firmagon ® Is Indicated For Treatment Of Patients With Advanced Prostate Cancer. Firmagon Is A Gnrh Receptor Antagonist Indicated For Treatment Of Patients With Advanced Prostate Cancer. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Degarelix

Comments